Skip to content

Clinical trials

Completed Phase 2 Brain Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Status: Completed Clear all

287 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
20018
200210
200311
200410
200516
200617
200722
200813
200918
201012
201118
201210
20139
201412
201510
20168
20177
20184
20198
202011
20215
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed287

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)35
Duke University25
M.D. Anderson Cancer Center10
Memorial Sloan Kettering Cancer Center9
Children's Oncology Group6
European Organisation for Research and Treatment of Cancer - EORTC6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
Wake Forest University Health Sciences6
Northwestern University4
Novartis Pharmaceuticals4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms287
Glioblastoma129
Glioma83
Gliosarcoma81
Central Nervous System Neoplasms73
Astrocytoma66
Oligodendroglioma51
Breast Neoplasms25
Ependymoma23
Neoplasm Metastasis22

Trials

Showing 1 to 25 of 287. Each trial links to its page on Pharma Observatory.

187 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.